Vittoria Murro1, Dario Pasquale Mucciolo2, Andrea Sodi1, Ilaria Passerini3, Dario Giorgio1, Gianni Virgili1, Stanislao Rizzo1. 1. Department of Surgery and Translational Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. 2. Department of Surgery and Translational Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. dario.mucciolo@gmail.com. 3. Department of Genetic Diagnosis, Careggi Teaching Hospital, Florence, Italy.
Abstract
PURPOSE: To evaluate the clinical phenotype of autosomal recessive NR2E3-related retinal dystrophy. METHODS: We retrospectively studied 11 patients carrying out at least 2 NR2E3 mutations; they had undergone comprehensive ophthalmological examination, fundus photography, optical coherence tomography, electrophysiological testing, and visual field at the Regional Reference Center for Hereditary Retinal Degenerations of the Eye Clinic in Florence. RESULTS: Five females and six males with a diagnosis of NR2E3-related retinal dystrophy were included in the study. All patients complained of nyctalopia. Visual acuity ranged from 0.00 logMAR to hand motion. Two patients presented bull's eye maculopathy, and one of these was characterized by a triple hyper-autofluorescent ring at the fundus autofluorescence examination. Three patients showed small yellowish dots and spots at the mid-periphery. One patient was characterized by widespread subretinal drusenoid deposits (SDD) at the posterior pole. Four patients showed vitreous abnormalities. Optical coherence tomography (OCT) examinations detected variable degrees of abnormal retinal lamination and schitic changes. Seven patients were compound heterozygous and four were homozygous for mutations in NR2E3. CONCLUSIONS: Our study confirmed high variable phenotype in autosomal recessive NR2E3-related retinal dystrophy. Bull's eye maculopathy, subretinal drusenoid deposits, and foveal hypoplasia represent novel clinical findings in NR2E3-related retinal dystrophy. Macular involvement was detectable in all the patients, and the abnormal foveal avascular zone (FAZ) supports the role of NR2E3 in retinal development.
PURPOSE: To evaluate the clinical phenotype of autosomal recessive NR2E3-related retinal dystrophy. METHODS: We retrospectively studied 11 patients carrying out at least 2 NR2E3 mutations; they had undergone comprehensive ophthalmological examination, fundus photography, optical coherence tomography, electrophysiological testing, and visual field at the Regional Reference Center for Hereditary Retinal Degenerations of the Eye Clinic in Florence. RESULTS: Five females and six males with a diagnosis of NR2E3-related retinal dystrophy were included in the study. All patients complained of nyctalopia. Visual acuity ranged from 0.00 logMAR to hand motion. Two patients presented bull's eye maculopathy, and one of these was characterized by a triple hyper-autofluorescent ring at the fundus autofluorescence examination. Three patients showed small yellowish dots and spots at the mid-periphery. One patient was characterized by widespread subretinal drusenoid deposits (SDD) at the posterior pole. Four patients showed vitreous abnormalities. Optical coherence tomography (OCT) examinations detected variable degrees of abnormal retinal lamination and schitic changes. Seven patients were compound heterozygous and four were homozygous for mutations in NR2E3. CONCLUSIONS: Our study confirmed high variable phenotype in autosomal recessive NR2E3-related retinal dystrophy. Bull's eye maculopathy, subretinal drusenoid deposits, and foveal hypoplasia represent novel clinical findings in NR2E3-related retinal dystrophy. Macular involvement was detectable in all the patients, and the abnormal foveal avascular zone (FAZ) supports the role of NR2E3 in retinal development.
Authors: M Kobayashi; S Takezawa; K Hara; R T Yu; Y Umesono; K Agata; M Taniwaki; K Yasuda; K Umesono Journal: Proc Natl Acad Sci U S A Date: 1999-04-27 Impact factor: 11.205
Authors: N B Haider; S G Jacobson; A V Cideciyan; R Swiderski; L M Streb; C Searby; G Beck; R Hockey; D B Hanna; S Gorman; D Duhl; R Carmi; J Bennett; R G Weleber; G A Fishman; A F Wright; E M Stone; V C Sheffield Journal: Nat Genet Date: 2000-02 Impact factor: 38.330
Authors: S Gerber; J M Rozet; S I Takezawa; L C dos Santos; L Lopes; O Gribouval; C Penet; I Perrault; D Ducroq; E Souied; M Jeanpierre; S Romana; J Frézal; F Ferraz; R Yu-Umesono; A Munnich; J Kaplan Journal: Hum Genet Date: 2000-09 Impact factor: 4.132
Authors: David A R Bessant; Graham E Holder; Frederick W Fitzke; Annette M Payne; Shomi S Bhattacharya; Alan C Bird Journal: Arch Ophthalmol Date: 2003-06
Authors: Ann H Milam; Linda Rose; Artur V Cideciyan; Mark R Barakat; Wai-Xing Tang; Nisha Gupta; Tomas S Aleman; Alan F Wright; Edwin M Stone; Val C Sheffield; Samuel G Jacobson Journal: Proc Natl Acad Sci U S A Date: 2002-01-02 Impact factor: 11.205
Authors: Robert K Koenekoop; Magali Loyer; Collette K Hand; Huda Al Mahdi; Olga Dembinska; Raquel Beneish; Julie Racine; Guy A Rouleau Journal: Am J Ophthalmol Date: 2003-10 Impact factor: 5.258
Authors: Jin Kyun Oh; Yan Nuzbrokh; Winston Lee; Jose Ronaldo Lima de Carvalho; Nan Kai Wang; Janet R Sparrow; Rando Allikmets; Stephen H Tsang Journal: Eur J Ophthalmol Date: 2020-09-14 Impact factor: 2.597